Lexicon Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
LXRX
CUSIP
528872302
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 528872302 since 12/18/2024, newest first.

Filer % of Class Filed
FMR LLC 13G/A Amendment 4
11.7% 8/6/2026
Event 6/30/2026
Invus Global Management, LLC 13D/A Amendment 26
39.4% 5/8/2026
Event 4/30/2026
Invus Global Management, LLC 13D/A Amendment 25
36.2% 2/2/2026
Event 1/29/2026
FMR LLC 13G/A Amendment 3
10.5% 7/8/2025
Event 6/30/2025
FMR LLC 13G/A Amendment 2
9.6% 5/12/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 13 306 k $574 k
2026 Q2 155 365 M $878 M
2026 Q1 143 323 M $505 M
2025 Q4 132 260 M $299 M
2025 Q3 134 255 M $344 M
2025 Q2 132 257 M $244 M
2025 Q1 135 266 M $122 M
2024 Q4 135 298 M $220 M
2024 Q3 144 289 M $453 M
2024 Q2 138 282 M $476 M
2024 Q1 129 173 M $419 M
2023 Q4 118 187 M $286 M
2023 Q3 119 189 M $206 M
2023 Q2 131 191 M $438 M
2023 Q1 111 146 M $354 M
2022 Q4 113 148 M $283 M
2022 Q3 106 149 M $358 M
2022 Q2 94 119 M $221 M
2022 Q1 109 120 M $251 M
2021 Q4 124 122 M $480 M
2021 Q3 105 121 M $583 M
2021 Q2 121 118 M $542 M
2021 Q1 116 121 M $712 M
2020 Q4 120 122 M $418 M
2020 Q3 100 104 M $150 M
2020 Q2 116 107 M $214 M
2020 Q1 125 105 M $205 M
2019 Q4 128 108 M $448 M
2019 Q3 117 103 M $311 M
2019 Q2 130 106 M $669 M
2019 Q1 137 104 M $582 M
2018 Q4 135 106 M $703 M
2018 Q3 138 108 M $1.16 B
2018 Q2 137 109 M $1.31 B
2018 Q1 137 110 M $943 M
2017 Q4 146 111 M $1.10 B
2017 Q3 154 115 M $1.41 B
2017 Q2 148 115 M $1.89 B
2017 Q1 150 114 M $1.64 B
2016 Q4 157 111 M $1.53 B
2016 Q3 153 110 M $2.00 B
2016 Q2 146 111 M $1.59 B
2016 Q1 136 111 M $1.32 B
2015 Q4 129 110 M $1.47 B
2015 Q3 109 106 M $1.14 B
2015 Q2 89 96.9 M $780 M